Type 1 diabetes

Comparison of Serum Creatinine– and Cystatin C–Based Estimated Glomerular Filtration Rate (eGFR) at Baseline and Their Prediction of Incident Moderate Albuminuria in Individuals With Type 1 Diabetes

Diabetes CarePublished Cohort study

Authors' conclusion

These findings suggest SCysC may facilitate early identification of individuals at risk for albuminuria.

Study context

Population
FinnDiane Study participants with T1D without kidney failure, with serum creatinine (SCr) and serum cystatin C (SCysC) data; 51.8% men; median age 36.6 (IQR 27.7–46.4) years; median DM duration 19.5 (IQR 10.9–29.2) years
Participants
3,769 participants
Exposure
Cystatin C–based eGFR vs creatinine-based eGFR
Outcome
Concordance between SCr- and SCysC-based eGFR
Follow-up
Baseline

Main finding

As reported in the abstract

eGFRcys–eGFRcr concordance/discordance
Mean absolute eGFRdiff
14.0 ± 12.2 mL/min/1.73 m²

Observational data: associations, not effects.

Further findings

Factors contributing to discordance

Sex, albuminuria status, smoking, retinal laser photocoagulation, HbA1c, HDL cholesterol, hs-CRP and insulin dose per kg contributed to discordance

Incident moderate albuminuria

SCysC and eGFRcys associated with incident moderate albuminuria; EGFR of creatinine (eGFRcr) not

Original publication

Comparison of Serum Creatinine– and Cystatin C–Based eGFR at Baseline and Their Prediction of Incident Moderate Albuminuria in Individuals With Type 1 Diabetes. Diabetes Care. Published 2 April 2025. doi:10.2337/dc24-2519

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.